Metraipolis › archive › dc_4c3a0494875f

Efficacy and Safety of Tofacitinib in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Real-World Study — Europe PMC PMID:41246665

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41246665
DOI
10.7759/cureus.94745
License (as archived)
solo-consultazione
Archived
2026-11-09T06:36:33.810Z
SHA-256 of the archived text
951500437154e933726574041a69558adb9c8a4c4a7ba330c158f1a7621abad2
Stable URL of this page
https://metraipolis.com/documento/dc_4c3a0494875f

How to cite

Efficacy and Safety of Tofacitinib in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Real-World Study — Europe PMC PMID:41246665 — Europe PMC (en), https://europepmc.org/article/MED/41246665 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c3a0494875f (Metraipolis archive dc_4c3a0494875f, sha256 951500437154e933726574041a69558adb9c8a4c4a7ba330c158f1a7621abad2)
BibTeX
@misc{dc4c3a0494875f,
  title = {Efficacy and Safety of Tofacitinib in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Real-World Study — Europe PMC PMID:41246665},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41246665},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c3a0494875f; sha256 951500437154e933726574041a69558adb9c8a4c4a7ba330c158f1a7621abad2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41246665. Agents can read the archived copy with the MCP tool read_document.